-
1
-
-
0031685620
-
TGF-β signal transduction
-
Massague J. TGF-β signal transduction. Annu Rev Biochem 1998;67: 753-91.
-
(1998)
Annu Rev Biochem
, vol.67
, pp. 753-791
-
-
Massague, J.1
-
2
-
-
0031684855
-
Extracellular matrix-associated transforming growth factor-β: Role in cancer cell growth and invasion
-
Taipale J, Saharinen J, Keski-Oja J. Extracellular matrix-associated transforming growth factor-β: role in cancer cell growth and invasion. Adv Cancer Res 1998;75:87-134.
-
(1998)
Adv Cancer Res
, vol.75
, pp. 87-134
-
-
Taipale, J.1
Saharinen, J.2
Keski-Oja, J.3
-
3
-
-
0032415040
-
Cellular and extracellular biology of the latent transforming growth factor-β binding proteins
-
Sinha S, Nevett C, Shuttleworth CA, Kielty CM. Cellular and extracellular biology of the latent transforming growth factor-β binding proteins. Matrix Biol 1998;17:529-45.
-
(1998)
Matrix Biol
, vol.17
, pp. 529-545
-
-
Sinha, S.1
Nevett, C.2
Shuttleworth, C.A.3
Kielty, C.M.4
-
4
-
-
12344320716
-
Thrombospondin-1 a major activator of TGF-β1 in vivo
-
Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 a major activator of TGF-β1 in vivo. Cell 1998;93:1159-70.
-
(1998)
Cell
, vol.93
, pp. 1159-1170
-
-
Crawford, S.E.1
Stellmach, V.2
Murphy-Ullrich, J.E.3
-
5
-
-
0028825543
-
Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors?
-
Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 1995;83:357-60.
-
(1995)
Cell
, vol.83
, pp. 357-360
-
-
Schlessinger, J.1
Lax, I.2
Lemmon, M.3
-
6
-
-
0032763469
-
Specificity, diversity, and regulation in TGF-β superfamily signaling
-
Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 1999;13:2105-24.
-
(1999)
FASEB J
, vol.13
, pp. 2105-2124
-
-
Piek, E.1
Heldin, C.H.2
Ten Dijke, P.3
-
7
-
-
0028170226
-
Mechanism of activation of the TGF-β receptor
-
Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-7.
-
(1994)
Nature
, vol.370
, pp. 341-347
-
-
Wrana, J.L.1
Attisano, L.2
Wieser, R.3
Ventura, F.4
Massague, J.5
-
8
-
-
0030768644
-
TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4
-
Nakao A, Imamura T, Souchelnytskyi S, et al. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997;16:5353-62.
-
(1997)
EMBO J
, vol.16
, pp. 5353-5362
-
-
Nakao, A.1
Imamura, T.2
Souchelnytskyi, S.3
-
9
-
-
0030990236
-
Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-β
-
Ravitz MJ, Wenner CE. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-β. Adv Cancer Res 1997;71:165-207.
-
(1997)
Adv Cancer Res
, vol.71
, pp. 165-207
-
-
Ravitz, M.J.1
Wenner, C.E.2
-
10
-
-
0025222517
-
The transforming growth factor-β family
-
Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
-
(1990)
Annu Rev Cell Biol
, vol.6
, pp. 597-641
-
-
Massague, J.1
-
11
-
-
0033015710
-
Role of transforming growth factor-β 1 in invasion and metastasis in gastric carcinoma
-
Maehara Y, Kakeji Y, Kabashima A, et al. Role of transforming growth factor-β 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 1999;17:607-14.
-
(1999)
J Clin Oncol
, vol.17
, pp. 607-614
-
-
Maehara, Y.1
Kakeji, Y.2
Kabashima, A.3
-
12
-
-
0031106404
-
Transforming growth factor-β: Vasculogenesis, angiogenesis, and vessel wall integrity
-
Pepper MS. Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997;8:21-43.
-
(1997)
Cytokine Growth Factor Rev
, vol.8
, pp. 21-43
-
-
Pepper, M.S.1
-
13
-
-
0029074681
-
Defective haematopoiesis and vasculogenesis in transforming growth factor-β 1 knock out mice
-
Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-β 1 knock out mice. Development 1995;121:1845-54.
-
(1995)
Development
, vol.121
, pp. 1845-1854
-
-
Dickson, M.C.1
Martin, J.S.2
Cousins, F.M.3
Kulkarni, A.B.4
Karlsson, S.5
Akhurst, R.J.6
-
14
-
-
0030579203
-
TGF-β receptor type II deficiency results in defects of yolk sac hematopoicsis and vasculogenesis
-
Oshima M, Oshima H, Taketo MM. TGF-β receptor type II deficiency results in defects of yolk sac hematopoicsis and vasculogenesis. Dev Biol 1996;179:297-302.
-
(1996)
Dev Biol
, vol.179
, pp. 297-302
-
-
Oshima, M.1
Oshima, H.2
Taketo, M.M.3
-
15
-
-
0029611184
-
Up-regulation of endoglin on vascular endothelial cells in human solid tumors: Implications for diagnosis and therapy
-
Burrows FJ, Derbyshire EJ, Tazzari PL, et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1995;1:1623-34.
-
(1995)
Clin Cancer Res
, vol.1
, pp. 1623-1634
-
-
Burrows, F.J.1
Derbyshire, E.J.2
Tazzari, P.L.3
-
16
-
-
0031944290
-
Regulation of immune responses by TGF-β
-
Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 1998;16:137-61.
-
(1998)
Annu Rev Immunol
, vol.16
, pp. 137-161
-
-
Letterio, J.J.1
Roberts, A.B.2
-
17
-
-
0026799402
-
Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease
-
Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9.
-
(1992)
Nature
, vol.359
, pp. 693-699
-
-
Shull, M.M.1
Ormsby, I.2
Kier, A.B.3
-
18
-
-
0033104503
-
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsivencss to TGF-β
-
Yang X, Letterio JJ, Lechleider RJ, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsivencss to TGF-β. EMBO J 1999;18:1280-91.
-
(1999)
EMBO J
, vol.18
, pp. 1280-1291
-
-
Yang, X.1
Letterio, J.J.2
Lechleider, R.J.3
-
20
-
-
2642614530
-
Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
-
Tang B, Bottinger EP, Jakowlew SB, et al. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 1998;4:802-7
-
(1998)
Nat Med
, vol.4
, pp. 802-807
-
-
Tang, B.1
Bottinger, E.P.2
Jakowlew, S.B.3
-
21
-
-
0032489508
-
Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
-
Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998;92:645-56.
-
(1998)
Cell
, vol.92
, pp. 645-656
-
-
Takaku, K.1
Oshima, M.2
Miyoshi, H.3
Matsui, M.4
Seldin, M.F.5
Taketo, M.M.6
-
22
-
-
0032544448
-
Smad3 mutant mice develop metastatic colorectal cancer
-
Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998;94:703-14.
-
(1998)
Cell
, vol.94
, pp. 703-714
-
-
Zhu, Y.1
Richardson, J.A.2
Parada, L.F.3
Graff, J.M.4
-
23
-
-
7844240481
-
Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells
-
Villanueva A, Garcia C, Paules AB, et al. Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells. Oncogene 1998;17:1969-78.
-
(1998)
Oncogene
, vol.17
, pp. 1969-1978
-
-
Villanueva, A.1
Garcia, C.2
Paules, A.B.3
-
24
-
-
0033555627
-
Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers
-
Grady WM, Myeroff LL, Swinler SE, et al. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res 1999;59:320-4.
-
(1999)
Cancer Res
, vol.59
, pp. 320-324
-
-
Grady, W.M.1
Myeroff, L.L.2
Swinler, S.E.3
-
25
-
-
0029066689
-
Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
-
Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
-
(1995)
Science
, vol.268
, pp. 1336-1338
-
-
Markowitz, S.1
Wang, J.2
Myeroff, L.3
-
26
-
-
0028785602
-
A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellitc instability
-
Myeroff LL, Parsons R, Kim SJ, et al. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellitc instability. Cancer Res 1995;55:5545-7.
-
(1995)
Cancer Res
, vol.55
, pp. 5545-5547
-
-
Myeroff, L.L.1
Parsons, R.2
Kim, S.J.3
-
27
-
-
0029938791
-
A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma
-
Knaus PI, Lindemann D, DeCoteau FJ, et al. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 1996;16:3480-9.
-
(1996)
Mol Cell Biol
, vol.16
, pp. 3480-3489
-
-
Knaus, P.I.1
Lindemann, D.2
DeCoteau, F.J.3
-
28
-
-
0028075837
-
Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
-
Sun L, Wu G, Willson JK, et al. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chcm 1994;269:26449-55.
-
(1994)
J Biol Chcm
, vol.269
, pp. 26449-26455
-
-
Sun, L.1
Wu, G.2
Willson, J.K.3
-
29
-
-
0030593038
-
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
-
Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
-
(1996)
Science
, vol.271
, pp. 350-353
-
-
Hahn, S.A.1
Schutte, M.2
Hoque, A.T.3
-
30
-
-
15844390729
-
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers
-
Thiagalingam S, Lengauer C, Leach FS, et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996;13:343-6.
-
(1996)
Nat Genet
, vol.13
, pp. 343-346
-
-
Thiagalingam, S.1
Lengauer, C.2
Leach, F.S.3
-
31
-
-
0032524069
-
Mutations in the SMAD4/DPC4 gene in juvenile polyposis
-
Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086-8.
-
(1998)
Science
, vol.280
, pp. 1086-1088
-
-
Howe, J.R.1
Roth, S.2
Ringold, J.C.3
-
32
-
-
0032498328
-
Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers
-
Arai T, Akiyama Y, Okabe S, Ando M, Endo M, Yuasa Y. Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers. Cancer Lett 1998;122:157-63.
-
(1998)
Cancer Lett
, vol.122
, pp. 157-163
-
-
Arai, T.1
Akiyama, Y.2
Okabe, S.3
Ando, M.4
Endo, M.5
Yuasa, Y.6
-
33
-
-
0028981277
-
Peeper DS. p53-Dependent repression of CDK4 translation in TGF-β-induced G1 cell-cycle arrest
-
Ewen ME, Oliver CJ, Sluss HK, Miller SJ, Peeper DS. p53-Dependent repression of CDK4 translation in TGF-β-induced G1 cell-cycle arrest. Genes Dev 1995;9:204-17.
-
(1995)
Genes Dev
, vol.9
, pp. 204-217
-
-
Ewen, M.E.1
Oliver, C.J.2
Sluss, H.K.3
Miller, S.J.4
-
34
-
-
0028910316
-
Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth actor β 1
-
Alexandrow MG, Kawabata M, Aakre M, Moses HL. Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth actor β 1. Proc Natl Acad Sci U S A 1995;92:3239-43.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 3239-3243
-
-
Alexandrow, M.G.1
Kawabata, M.2
Aakre, M.3
Moses, H.L.4
-
35
-
-
0030938916
-
The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p15/INK4B
-
Datto MB, Hu PP, Kowalik TF, Yingling J, Wang XF. The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol Cell Biol 1997;17:2030-7.
-
(1997)
Mol Cell Biol
, vol.17
, pp. 2030-2037
-
-
Datto, M.B.1
Hu, P.P.2
Kowalik, T.F.3
Yingling, J.4
Wang, X.F.5
-
36
-
-
0033106484
-
A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras
-
Kretzschmar M, Doody J, Timokhina I, Massague J. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev 1999; 13:804-16.
-
(1999)
Genes Dev
, vol.13
, pp. 804-816
-
-
Kretzschmar, M.1
Doody, J.2
Timokhina, I.3
Massague, J.4
-
37
-
-
0033595799
-
A new blocker for the TGF-β pathway
-
Vogel G. A new blocker for the TGF-β pathway. Science 1999;286: 665.
-
(1999)
Science
, vol.286
, pp. 665
-
-
Vogel, G.1
-
38
-
-
0033545299
-
Cyclosporine induces cancer progression by a cell-autonomous mechanism
-
Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999;397:530-4.
-
(1999)
Nature
, vol.397
, pp. 530-534
-
-
Hojo, M.1
Morimoto, T.2
Maluccio, M.3
-
39
-
-
0031948084
-
A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor β1
-
Picon A, Gold LI, Wang J, Cohen A, Friedman E. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor β1. Cancer Epidemiol Biomarkers Prev 1998;7:497-504.
-
(1998)
Cancer Epidemiol Biomarkers Prev
, vol.7
, pp. 497-504
-
-
Picon, A.1
Gold, L.I.2
Wang, J.3
Cohen, A.4
Friedman, E.5
-
40
-
-
0030598681
-
TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice
-
Cui W, Fowlis DJ, Bryson S, et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996;86:531-42.
-
(1996)
Cell
, vol.86
, pp. 531-542
-
-
Cui, W.1
Fowlis, D.J.2
Bryson, S.3
-
42
-
-
0028171579
-
Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
-
McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-51.
-
(1994)
Nat Genet
, vol.8
, pp. 345-351
-
-
McAllister, K.A.1
Grogg, K.M.2
Johnson, D.W.3
-
43
-
-
0030050973
-
Mutations in the activin receptor like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
-
Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-95.
-
(1996)
Nat Genet
, vol.13
, pp. 189-195
-
-
Johnson, D.W.1
Berg, J.N.2
Baldwin, M.A.3
-
44
-
-
7144222768
-
Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles
-
Gallione CJ, Klaus DJ, Yeh EY, et al. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat 1998;11:286-94.
-
(1998)
Hum Mutat
, vol.11
, pp. 286-294
-
-
Gallione, C.J.1
Klaus, D.J.2
Yeh, E.Y.3
-
45
-
-
0033537831
-
Assignment of transforming growth factor β1 and β3 and a third new ligand to the type I receptor ALK-1
-
Lux A, Attisano L, Marchuk DA. Assignment of transforming growth factor β1 and β3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 1999;274:9984-92.
-
(1999)
J Biol Chem
, vol.274
, pp. 9984-9992
-
-
Lux, A.1
Attisano, L.2
Marchuk, D.A.3
-
46
-
-
0033612141
-
Defective angiogenesis in mice lacking endoglin
-
Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science 1999;284:1534-7
-
(1999)
Science
, vol.284
, pp. 1534-1537
-
-
Li, D.Y.1
Sorensen, L.K.2
Brooke, B.S.3
-
47
-
-
12944273545
-
ALK-1 modulates TGF β-1 signaling in the regulation of angiogenesis
-
Oh SP, Seki T, Goss KA, et al. ALK-1 modulates TGF β-1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 2000;97: 2626-31.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 2626-2631
-
-
Oh, S.P.1
Seki, T.2
Goss, K.A.3
-
49
-
-
0028109801
-
Transforming growth factor β in tissue fibrosis
-
Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-92.
-
(1994)
N Engl J Med
, vol.331
, pp. 1286-1292
-
-
Border, W.A.1
Noble, N.A.2
-
50
-
-
0028953768
-
Hepatic expression of mature transforming growth factor β 1 in transgenic mice results in multiple tissue lesions
-
Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor β 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 1995;92:2572-6.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 2572-2576
-
-
Sanderson, N.1
Factor, V.2
Nagy, P.3
-
51
-
-
0029953788
-
Transgenic mice with increased plasma levels of TGF-β 1 develop progressive renal disease
-
Kopp JB, Factor VM, Mozes M, et al. Transgenic mice with increased plasma levels of TGF-β 1 develop progressive renal disease. Lab Invest 1996;74:991-1003.
-
(1996)
Lab Invest
, vol.74
, pp. 991-1003
-
-
Kopp, J.B.1
Factor, V.M.2
Mozes, M.3
-
52
-
-
0031667368
-
Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women
-
Yamada Y, Miyauchi A, Goto J, et al. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998; 13:1569-76.
-
(1998)
J Bone Miner Res
, vol.13
, pp. 1569-1576
-
-
Yamada, Y.1
Miyauchi, A.2
Goto, J.3
-
53
-
-
0032958714
-
Genetic control of the circulating concentration of transforming growth actor type β1
-
Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth actor type β1. Hum Mol Genet 1999;8:93-7.
-
(1999)
Hum Mol Genet
, vol.8
, pp. 93-97
-
-
Grainger, D.J.1
Heathcote, K.2
Chiano, M.3
-
54
-
-
0032609711
-
TGF-β1 DNA polymorphisms, protein levels, and blood pressure
-
Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-β1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999;33:271-5.
-
(1999)
Hypertension
, vol.33
, pp. 271-275
-
-
Li, B.1
Khanna, A.2
Sharma, V.3
Singh, T.4
Suthanthiran, M.5
August, P.6
-
55
-
-
0032573136
-
Genotypic variation in the transforming growth factor-β1 gene: Association with transforming growth factor-β1 production, fibrotic lung disease, and graft fibrosis after lung transplantation
-
Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene: association with transforming growth factor-β1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66:1014-20.
-
(1998)
Transplantation
, vol.66
, pp. 1014-1020
-
-
Awad, M.R.1
El-Gamel, A.2
Hasleton, P.3
Turner, D.M.4
Sinnott, P.J.5
Hutchinson, I.V.6
-
56
-
-
0027989926
-
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
-
Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature 1994;370:460-2.
-
(1994)
Nature
, vol.370
, pp. 460-462
-
-
Grainger, D.J.1
Kemp, P.R.2
Liu, A.C.3
Lawn, R.M.4
Metcalfe, J.C.5
-
57
-
-
0028850239
-
Tamoxifen elevates transforming growth factor-β and suppresses diet-induced formation of lipid lesions in mouse aorta
-
Grainger DJ, Witchell CM, Metcalfe JC. Tamoxifen elevates transforming growth factor-β and suppresses diet-induced formation of lipid lesions in mouse aorta. Nat Med 1995;1:1067-73.
-
(1995)
Nat Med
, vol.1
, pp. 1067-1073
-
-
Grainger, D.J.1
Witchell, C.M.2
Metcalfe, J.C.3
-
58
-
-
0028859484
-
Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions: Conversion from an antiproliferative to profibrotic response to TGF-β1
-
McCaffrey TA, Consigli S, Du B, et al. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions: conversion from an antiproliferative to profibrotic response to TGF-β1. J Clin Invest 1995;96:2667-75.
-
(1995)
J Clin Invest
, vol.96
, pp. 2667-2675
-
-
McCaffrey, T.A.1
Consigli, S.2
Du, B.3
-
59
-
-
0030704297
-
Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells
-
McCaffrey TA, Du B, Consigli S, et al. Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 1997;100:2182-8.
-
(1997)
J Clin Invest
, vol.100
, pp. 2182-2188
-
-
McCaffrey, T.A.1
Du, B.2
Consigli, S.3
-
60
-
-
0029096747
-
Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial
-
McDonald CC, Alexander FE, Whyte BW, Forrest AP, Stewart HJ. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. BMJ 1995;311:977-80.
-
(1995)
BMJ
, vol.311
, pp. 977-980
-
-
McDonald, C.C.1
Alexander, F.E.2
Whyte, B.W.3
Forrest, A.P.4
Stewart, H.J.5
-
61
-
-
0032866397
-
The expression of TGF-β receptors in human atherosclerosis: Evidence for acquired resistance to apoptosis due to receptor imbalance
-
McCaffrey TA, Du B, Fu C, et al. The expression of TGF-β receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol 1999;31:627-42.
-
(1999)
J Mol Cell Cardiol
, vol.31
, pp. 627-642
-
-
McCaffrey, T.A.1
Du, B.2
Fu, C.3
-
62
-
-
0030609894
-
TGFβ2 knockout mice have multiple developmental defects that are nonoverlapping with other TGFβ knockout phenotypes
-
Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. TGFβ2 knockout mice have multiple developmental defects that are nonoverlapping with other TGFβ knockout phenotypes. Development 1997;124:2659-70.
-
(1997)
Development
, vol.124
, pp. 2659-2670
-
-
Sanford, L.P.1
Ormsby, I.2
Gittenberger-De Groot, A.C.3
-
63
-
-
0028972869
-
Transforming growth factor-β 3 is required for secondary palate fusion
-
Proetzel G, Pawlowski SA, Wiles MV, et al. Transforming growth factor-β 3 is required for secondary palate fusion. Nat Genet 1995;11:409-14.
-
(1995)
Nat Genet
, vol.11
, pp. 409-414
-
-
Proetzel, G.1
Pawlowski, S.A.2
Wiles, M.V.3
-
64
-
-
0032231873
-
Association of MSX1 and TGFB3 with nonsyndromic clefting in humans
-
Lidral AC, Romitti PA, Basart AM, et al. Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet 1998; 63:557-68.
-
(1998)
Am J Hum Genet
, vol.63
, pp. 557-568
-
-
Lidral, A.C.1
Romitti, P.A.2
Basart, A.M.3
-
65
-
-
0032989710
-
Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation of genotype-environment interactions from a population-based control study of orofacial clefts
-
Romitti PA, Lidral AC, Munger RG, Daack-Hirsch S, Burns TL, Murray JC. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: evaluation of genotype-environment interactions from a population-based control study of orofacial clefts. Teratology 1999;59:39-50.
-
(1999)
Teratology
, vol.59
, pp. 39-50
-
-
Romitti, P.A.1
Lidral, A.C.2
Munger, R.G.3
Daack-Hirsch, S.4
Burns, T.L.5
Murray, J.C.6
-
66
-
-
0032521047
-
Peaks of transforming growth factor-β mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection
-
Charpin JM, Valcke J, Kettanch L, Epardeau B, Stern M, Israel-Biet D. Peaks of transforming growth factor-β mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. Transplantation 1998;65:752-5.
-
(1998)
Transplantation
, vol.65
, pp. 752-755
-
-
Charpin, J.M.1
Valcke, J.2
Kettanch, L.3
Epardeau, B.4
Stern, M.5
Israel-Biet, D.6
-
67
-
-
0031761121
-
Transforming growth factor β1 (TGF-β1) is a preoperative prognostic indicator in advanced gastric carcinoma
-
Nakamura M, Katano M, Kuwahara A, et al. Transforming growth factor β1 (TGF-β1) is a preoperative prognostic indicator in advanced gastric carcinoma. Br J Cancer 1998;78:1373-8.
-
(1998)
Br J Cancer
, vol.78
, pp. 1373-1378
-
-
Nakamura, M.1
Katano, M.2
Kuwahara, A.3
-
68
-
-
0028902318
-
Elevated plasma levels of TGF-β 1 in patients with invasive prostate cancer
-
Ivanovic V, Melman A, Davis-Joseph B, Valcic M, Geliebter J. Elevated plasma levels of TGF-β 1 in patients with invasive prostate cancer. Nat Med 1995;1:282-4.
-
(1995)
Nat Med
, vol.1
, pp. 282-284
-
-
Ivanovic, V.1
Melman, A.2
Davis-Joseph, B.3
Valcic, M.4
Geliebter, J.5
-
69
-
-
0006335227
-
Elevated serum levels of transforming growth factor-β1 in patients with colorectal carcinoma: Its association with tumor progression and its significant decrease after curative surgical resection
-
Shim KS, Kim KH, Han WS, Park EB. Elevated serum levels of transforming growth factor-β1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection. Cancer 1999;85:554-61.
-
(1999)
Cancer
, vol.85
, pp. 554-561
-
-
Shim, K.S.1
Kim, K.H.2
Han, W.S.3
Park, E.B.4
-
70
-
-
0031785045
-
Plasma transforming growth factor-β 1 concentrations in patients with chronic viral hepatitis
-
Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Plasma transforming growth factor-β 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1998;13.680-4.
-
(1998)
J Gastroenterol Hepatol
, vol.13
, pp. 680-684
-
-
Murawaki, Y.1
Nishimura, Y.2
Ikuta, Y.3
Idobe, Y.4
Kitamura, Y.5
Kawasaki, H.6
-
71
-
-
0030961335
-
Elevated urinary transforming growth factor-β1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma
-
Tsai JF, Jeng JE, Chuang LY, et al. Elevated urinary transforming growth factor-β1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. Br J Cancer 1997;76:244-50.
-
(1997)
Br J Cancer
, vol.76
, pp. 244-250
-
-
Tsai, J.F.1
Jeng, J.E.2
Chuang, L.Y.3
-
72
-
-
0032589002
-
TGF-β1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
-
Li C, Wilson PB, Levine E, Barber J, Steward AL, Kumar S. TGF-β1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer 1999;84:155-9.
-
(1999)
Int J Cancer
, vol.84
, pp. 155-159
-
-
Li, C.1
Wilson, P.B.2
Levine, E.3
Barber, J.4
Steward, A.L.5
Kumar, S.6
-
73
-
-
0027193827
-
Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer
-
Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993;328:1592-8.
-
(1993)
N Engl J Med
, vol.328
, pp. 1592-1598
-
-
Anscher, M.S.1
Peters, W.P.2
Reisenbichler, H.3
Petros, W.P.4
Jirtle, R.L.5
-
74
-
-
0033556556
-
Serum transforming growth factor-β1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease
-
Liem LM, Fibbe WE, van Houwelingen HC, Goulmy E. Serum transforming growth factor-β1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation 1999;67:59-65.
-
(1999)
Transplantation
, vol.67
, pp. 59-65
-
-
Liem, L.M.1
Fibbe, W.E.2
Van Houwelingen, H.C.3
Goulmy, E.4
-
75
-
-
0031743408
-
Persistent transforming growth factor-β 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence
-
Lin CY, Chen WP, Yang LY, Chen A, Huang TP. Persistent transforming growth factor-β 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Am J Nephrol 1998;18:513-9.
-
(1998)
Am J Nephrol
, vol.18
, pp. 513-519
-
-
Lin, C.Y.1
Chen, W.P.2
Yang, L.Y.3
Chen, A.4
Huang, T.P.5
-
76
-
-
0028788450
-
Transforming growth factor β 2 (TGF-β 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen
-
Kopp A, Jonat W, Schmahl M, Knabbe C. Transforming growth factor β 2 (TGF-β 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. Cancer Res 1995;55:4512-5.
-
(1995)
Cancer Res
, vol.55
, pp. 4512-4515
-
-
Kopp, A.1
Jonat, W.2
Schmahl, M.3
Knabbe, C.4
-
77
-
-
0031766398
-
Combination of bone marrow and TGF-β1 augment the healing of critical-sized bone defects
-
Beck LS, Wong RL, DeGuzman L, Lee WP, Ongpipattanakul B, Nguyen TH. Combination of bone marrow and TGF-β1 augment the healing of critical-sized bone defects. J Pharm Sci 1998;87:1379-86.
-
(1998)
J Pharm Sci
, vol.87
, pp. 1379-1386
-
-
Beck, L.S.1
Wong, R.L.2
DeGuzman, L.3
Lee, W.P.4
Ongpipattanakul, B.5
Nguyen, T.H.6
-
78
-
-
0027136263
-
A major advance in the use of growth factors to enhance wound healing
-
Sporn MB, Roberts AB. A major advance in the use of growth factors to enhance wound healing. J Clin Invest 1993;92:2565-6.
-
(1993)
J Clin Invest
, vol.92
, pp. 2565-2566
-
-
Sporn, M.B.1
Roberts, A.B.2
-
79
-
-
0028353873
-
Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor β 3
-
Sonis ST, Lindquist L, Van Vugt A, et al. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor β 3. Cancer Res 1994;54:1135-8.
-
(1994)
Cancer Res
, vol.54
, pp. 1135-1138
-
-
Sonis, S.T.1
Lindquist, L.2
Van Vugt, A.3
-
80
-
-
0030903741
-
Pretreatment with transforming growth factor β-3 protects small intestinal stem cells against radiation damage in vivo
-
Potten CS, Booth D, Haley JD. Pretreatment with transforming growth factor β-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer 1997;75:1454-9.
-
(1997)
Br J Cancer
, vol.75
, pp. 1454-1459
-
-
Potten, C.S.1
Booth, D.2
Haley, J.D.3
-
81
-
-
0029905441
-
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
-
Isaka Y, Brees DK, Ikegaya K, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2:418-23.
-
(1996)
Nat Med
, vol.2
, pp. 418-423
-
-
Isaka, Y.1
Brees, D.K.2
Ikegaya, K.3
-
82
-
-
0033515099
-
Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat
-
Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A 1999;96:2345-9.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 2345-2349
-
-
Qi, Z.1
Atsuchi, N.2
Ooshima, A.3
Takeshita, A.4
Ueno, H.5
-
83
-
-
0032719815
-
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
-
Nakao A, Fujii M, Matsumura R, et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999;104:5-11.
-
(1999)
J Clin Invest
, vol.104
, pp. 5-11
-
-
Nakao, A.1
Fujii, M.2
Matsumura, R.3
-
84
-
-
0032821129
-
Human anti-transforming growth factor-β2 antibody: A new glaucoma anti-scarring agent
-
Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-β2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 1999;40:2225-34.
-
(1999)
Invest Ophthalmol Vis Sci
, vol.40
, pp. 2225-2234
-
-
Cordeiro, M.F.1
Gay, J.A.2
Khaw, P.T.3
-
85
-
-
0025855367
-
Transforming growth factors β1 and α in chronic liver disease: Effects of interferon alfa therapy
-
Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease: effects of interferon alfa therapy. N Engl J Med 1991;324:933-40.
-
(1991)
N Engl J Med
, vol.324
, pp. 933-940
-
-
Castilla, A.1
Prieto, J.2
Fausto, N.3
-
86
-
-
0030924446
-
Angiotensin II in renal fibrosis: Should TGF-β rather than blood pressure be the therapeutic target?
-
Noble NA, Border WA. Angiotensin II in renal fibrosis: should TGF-β rather than blood pressure be the therapeutic target? Semin Nephrol 1997;17:455-66.
-
(1997)
Semin Nephrol
, vol.17
, pp. 455-466
-
-
Noble, N.A.1
Border, W.A.2
-
87
-
-
0032079771
-
Transforming growth factor-β1 in autoimmune hepatitis: Correlation of liver tissue expression and serum levels with disease activity
-
Bayer EM, Herr W, Kanzler S, et al. Transforming growth factor-β1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J Hepatol 1998;28:803-11.
-
(1998)
J Hepatol
, vol.28
, pp. 803-811
-
-
Bayer, E.M.1
Herr, W.2
Kanzler, S.3
-
88
-
-
0032955814
-
Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-alpha therapy: Association with regression of hepatic fibrosis
-
Tsushima H, Kawata S, Tamura S, et al. Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis. J Hepatol 1999;30:1-7.
-
(1999)
J Hepatol
, vol.30
, pp. 1-7
-
-
Tsushima, H.1
Kawata, S.2
Tamura, S.3
-
89
-
-
0033592753
-
A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis
-
Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block L-H. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264-9.
-
(1999)
N Engl J Med
, vol.341
, pp. 1264-1269
-
-
Ziesche, R.1
Hofbauer, E.2
Wittmann, K.3
Petkov, V.4
Block, L.-H.5
-
90
-
-
0032784820
-
Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy
-
Campistol JM, Inigo P, Jimenez W, et al. Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy. Kidney Int 1999;56:714-9.
-
(1999)
Kidney Int
, vol.56
, pp. 714-719
-
-
Campistol, J.M.1
Inigo, P.2
Jimenez, W.3
-
91
-
-
0029898731
-
Tamoxifen: Teaching an old drug new tricks?
-
Grainger DJ, Metcalfe JC. Tamoxifen: teaching an old drug new tricks? Nat Med 1996;2:381-5.
-
(1996)
Nat Med
, vol.2
, pp. 381-385
-
-
Grainger, D.J.1
Metcalfe, J.C.2
-
92
-
-
0031026647
-
Induction of transforming growth factor β-1 in cervical intraepithelial neoplasia in vivo after treatment with β-carotene
-
Comerci JT Jr, Runowicz CD, Fields AL, et al. Induction of transforming growth factor β-1 in cervical intraepithelial neoplasia in vivo after treatment with β-carotene. Clin Cancer Res 1997;3:157-60.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 157-160
-
-
Comerci J.T., Jr.1
Runowicz, C.D.2
Fields, A.L.3
-
93
-
-
0038139474
-
Use of transforming growth factor β2 (TGF-β2) in treatment of chronic foot ulcers in diabetic patients
-
Bordeaux, France, August 28, abstract
-
Robson MC, Steed DL, McPherson JM, Pratt BM. Use of transforming growth factor β2 (TGF-β2) in treatment of chronic foot ulcers in diabetic patients. In: Proceedings of the Third Joint Meeting of the European Tissue Repair Society and the Wound Healing Society, Bordeaux, France, August 28, 1999. abstract.
-
(1999)
Proceedings of the Third Joint Meeting of the European Tissue Repair Society and the Wound Healing Society
-
-
Robson, M.C.1
Steed, D.L.2
McPherson, J.M.3
Pratt, B.M.4
|